Assessing Encompass Health (EHC) Valuation After Recent Share Price Volatility
Why Encompass Health is on investors’ radar today
Encompass Health (EHC) shares have drawn attention after recent trading moves, with the stock closing at $110.14 and showing mixed short term and past 3 months return patterns.
See our latest analysis for Encompass Health.
Recent trading has been choppy, with a 1 day share price return of a 1.71% decline but a 30 day share price return of 9.59%, while the 5 year total shareholder return of 83.86% points to stronger gains over a longer horizon.
If this move in a healthcare name has your attention, it could be a good moment to see what else is out there through our screener of 25 healthcare AI stocks.
With Encompass Health trading at $110.14 and some metrics suggesting up to a 23% intrinsic discount, the key question is simple: is there still a buying opportunity here, or is the market already pricing in future growth?
Most Popular Narrative: 22.8% Undervalued
At $110.14, Encompass Health sits below the most followed fair value estimate of $142.73, which is built from detailed revenue, margin and earnings assumptions, all discounted at 6.98%.
The surge in the 65 plus population and persistent undersupply of inpatient rehabilitation beds are driving high and still unmet demand for Encompass Health's core services; ongoing hospital openings and bed expansions position the company to capture significant incremental patient volume, supporting higher revenue growth for years to come.
Want to see what is behind that demand story and the $142.73 fair value marker? Revenue growth, profit margins and a future earnings multiple all play decisive roles, but the exact mix might surprise you.
Result: Fair Value of $142.73 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, that demand story could be challenged if labor shortages increase costs or if shifts toward outpatient and home based rehab start to pull volumes away.
Find out about the key risks to this Encompass Health narrative.
Build Your Own Encompass Health Narrative
If you see the story differently or want to test your own assumptions against the data, you can shape a complete view in just a few minutes: Do it your way.
A great starting point for your Encompass Health research is our analysis highlighting 5 key rewards and 2 important warning signs that could impact your investment decision.
Looking for more investment ideas?
If Encompass Health has sharpened your focus, do not stop here. A few minutes with the right screeners could surface opportunities you will not want to overlook.
- Target resilient income by checking out a hand picked group of 13 dividend fortresses that may suit investors who prioritize regular cash returns.
- Hunt for mispriced quality by scanning our 54 high quality undervalued stocks that combine strong fundamentals with potentially attractive entry points.
- Spot sturdier balance sheets by reviewing the solid balance sheet and fundamentals stocks screener (44 results) that focus on companies with financial positions many investors look for in uncertain periods.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com